Belmar Pharma Solutions

• Pharmacy Profile Name: Belmar Pharma Solutions
• Website: belmarpharmasolutions.com
• Founded: 1985, originating as a local compounding pharmacy in Denver, Colorado
• Headquarters: Colorado and Florida (multiple facilities nationwide)
• Phone: (800) 525-9473
• Pharmacy Type: 503A multi-facility compounding pharmacy + FDA-registered 503B outsourcing facility
• Accreditations: LegitScript certified; NABP accredited at all locations
• GLP-1 Compounding: Semaglutide, Tirzepatide, Liraglutide

About the Pharmacy

Belmar Pharma Solutions is one of the most established and widely referenced compounding pharmacy networks in the U.S. GLP-1 telehealth space. What began nearly 40 years ago as a local compounding pharmacy in Denver, Colorado has grown into a single-source solution for prescribers, patients, and healthcare facilities across the country. Belmar’s 503A compounding pharmacies have been filling patient-specific prescriptions since 1985.

The pharmacy is provider-facing rather than consumer-facing — patients cannot order directly from Belmar. Prescriptions must come from a licensed healthcare provider, typically through one of the many telehealth platforms that list Belmar as a partner pharmacy. This model, combined with Belmar’s longevity and credentials, has made it one of the most trusted pharmacy names cited across the compounded GLP-1 telehealth ecosystem.

GLP-1 Compounding

Belmar compounds a broader range of GLP-1 medications than most pharmacies in the compounded weight loss space, including:

• Compounded Semaglutide — injectable (with cyanocobalamin/B12 as a commonly added co-factor); the primary GLP-1 offering across its telehealth partner network
• Compounded Tirzepatide — injectable GIP/GLP-1 dual agonist
• Compounded Liraglutide — available as a daily subcutaneous injectable in combination with L-carnitine (25/10 mg/mL), offering a shorter half-life alternative for patients who struggle with the gastrointestinal side effects of weekly GLP-1 formulations

Belmar’s ingredients and compounds are tested and retested, randomly and continuously, by an independent lab throughout the entire chain from sourcing through distribution. Its vendor qualification program ensures all manufacturers and wholesalers it purchases from are registered and certified by the appropriate regulatory body, and Belmar goes one step further by confirming that each manufacturer’s own vendors are also compliant.

No FDA Warning Letter was found for Belmar Pharma Solutions in the FDA’s public enforcement action database as of March 2026.

Type of Pharmacy

Belmar Pharma Solutions operates two types of facilities: 503A Compounding Pharmacies and a 503B FDA-registered Outsourcing Facility. The 503B outsourcing facility is dedicated to the production of hormone pellets in bulk quantities for direct distribution to prescribers. The 503A facilities are traditional compounding pharmacies that produce individualized formulations based on specific patient prescriptions.

GLP-1 Weight Loss

• Lose pounds of fat every week
• Money Back Guarantee
• No membership or hidden fees! Everything you need is included
• Start for just $179, no insurance required + free shipping

GLP-1 for Just $179

100k MembersHSA/FSA ApprovedFrom $179

For GLP-1 medications specifically, Belmar operates through its 503A network, meaning each vial is compounded against an individual patient’s prescription rather than produced in advance in bulk. Belmar operates six 503A sterile and non-sterile facilities across the country, including two sterile pharmacies each in Colorado and Florida. Belmar is the only national compounding organization with LegitScript certification and NABP accreditation at all of its locations, a meaningful credential that sets it apart from the majority of compounders operating in the GLP-1 space.

States Licensed In

Belmar Pharma Solutions is licensed to ship to all 50 states. With six 503A facilities spread across Colorado and Florida, and a national logistics footprint built over four decades, Belmar has a broader geographic reach than most compounding pharmacies in this review series.

Telehealth Providers They Work With

Belmar is one of the most widely named pharmacy partners in the compounded GLP-1 telehealth ecosystem. Known, confirmed, and publicly named partner platforms include:

• MEDVi — MEDVi partners with Belmar Pharma Solutions and Beluga Health to provide GLP-1 medications and telehealth care by licensed providers
• OnlineSemaglutide.org — Belmar Pharmacy is named as one of the licensed compounding pharmacies in the CareGLP network that powers OnlineSemaglutide.org, alongside Strive Pharmacy and Epiq Scripts
• SynergyRx GLP-1 — lists Belmar Pharmacy as one of its pharmacy providers alongside Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx
• Trinity Meds — lists Belmar Pharmacy as a named partner pharmacy with its public phone number (800-525-9473) on its FAQ page

Belmar’s scale and reputation mean it is likely used by additional telehealth platforms that do not publicly disclose their pharmacy partners by name.

Pricing from Reviews

Belmar does not publish direct patient pricing; all GLP-1 pricing is determined by the telehealth platform through which the prescription is placed. Based on pricing visible through known Belmar partner platforms, patients can expect the following ranges for compounded GLP-1 medications dispensed by Belmar:

• Through MEDVi, compounded semaglutide injections start at $179 for the first month and $299 for subsequent months; compounded tirzepatide injections start at $279 for the first month and up to $399 ongoing
• Through OnlineSemaglutide.org: compounded semaglutide starting around $242/month for tirzepatide and comparable semaglutide pricing
• MEDVi’s Belmar-sourced semaglutide program is cited as starting at approximately $197/month all-inclusive in independent comparisons

Pricing varies by platform, plan length, and dose, and patients are not paying Belmar directly. The pharmacy’s role is fulfillment; the commercial relationship is with the telehealth platform.

Overall Reviews

Belmar Pharma Solutions does not have a consumer-facing Trustpilot or Google Business profile in the traditional sense, as it is a provider-facing pharmacy rather than a direct-to-patient retailer. Reviews of Belmar’s GLP-1 output appear primarily within the review records of the telehealth platforms it supplies most prominently, MEDVi, which carries a strong Trustpilot rating.

MEDVi’s partnership with Belmar is cited by independent review platforms as a positive quality signal, with Belmar’s decades-long track record and dual NABP/LegitScript accreditation noted as distinguishing it from newer, less-credentialed compounders that entered the GLP-1 space during the shortage era. Among pharmacy professionals and prescribers, Belmar’s name carries significant trust built over nearly four decades of operations and consistent regulatory compliance.

No significant negative patterns, adverse event reports attributable to Belmar’s compounded GLP-1 products, or FDA enforcement actions were found in public records as of March 2026.